Stigningen i overlevelse set i armen med ugentlig docetaxel var ikke statistisk signifikant sammenlignet med mitxantron kontrol- armen.
The increase in survival seen in the docetaxel weekly arm was not statistically significant compared to the mitoxantrone control arm.